Resources
Outcomes of a pharmacist intervention on diabetic patients
Problem: how can pharmacists play a greater role with diabetic patients?
Diabetes is a chronic disease that is increasingly prevalent in France and accounts for nearly 10% of health spending. The many complications associated with diabetes contribute substantially to this spending and occur when diabetes is insufficiently controlled. The current therapeutic objective of the treatment is measured by HbA1c levels, which should be <7% as defined by NHANES. In France, 41% of patients have HbA1c levels above 7%, and 15% above 8%. In parallel, many studies highlight adherence as an important success factor on HbA1c control.
In this context, pharmacists are essential actors in patient care, and, due to their expertise, wide presence, and accessibility, they could play a greater role in ensuring medical outcomes.
See also
Scientific communications
A multiple-cohort analysis of the SPUR 6/24 patient-reported adherence tool
Articles
Clinical Ink and Observia: Pioneering Personalized Patient Engagement in Clinical Trials
News